CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹92 Cr | ₹247 Cr | ₹520 Cr | ₹824 Cr | ₹1,756 Cr |
What is the latest Total Debt ratio of CIPLA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹92 Cr |
| Mar2024 | ₹247 Cr |
| Mar2023 | ₹520 Cr |
| Mar2022 | ₹824 Cr |
| Mar2021 | ₹1,756 Cr |
How is Total Debt of CIPLA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹92 Cr | -62.72 | |
| Mar2024 | ₹247 Cr | -52.53 | |
| Mar2023 | ₹520 Cr | -36.86 | |
| Mar2022 | ₹824 Cr | -53.06 | |
| Mar2021 | ₹1,756 Cr | - | |
Compare Total Debt of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹127,693.0 Cr | -3.9% | 5.5% | 5.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,822.0 Cr | 1.6% | 8.2% | -8.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,811.0 Cr | -0.8% | 14.4% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,840.0 Cr | -0.5% | 1% | 7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.1% | -0% | -2% | Stock Analytics | |
| MANKIND PHARMA | ₹100,903.0 Cr | -0.2% | -1.5% | -4.1% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -3.9% |
5.5% |
5.2% |
| SENSEX | 0.7% |
4.7% |
6.1% |
You may also like the below Video Courses